Format

Send to

Choose Destination
J Am Heart Assoc. 2013 Dec 11;2(6):e000536. doi: 10.1161/JAHA.113.000536.

The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.

Author information

1
Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL.

KEYWORDS:

cGMP; heart failure; phosphodiesterase 5; preserved ejection fraction; soluble guanylate cyclase

PMID:
24334823
PMCID:
PMC3886746
DOI:
10.1161/JAHA.113.000536
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center